Mankind Pharma has informed that the Nomination and Remuneration Committee of the Board of Directors of the Company vide circular resolution passed today, August 14, 2024, has allotted 9,000 equity shares of face value of Re 1 each of the Company to the eligible employees who have exercised their options pursuant to Employees Stock Option Plan 2022 (ESOP 2022).
The above information is a part of company’s filings submitted to BSE.